Day: March 11, 2022

RenovoRx to Participate March 2022 Investor Conferences

Business people having a meeting and shaking hands

RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today announced its leadership’s participation in two upcoming Investor Conferences this month.